Phase I-II Study Evaluating the Safety and Clinical Efficacy of Temsirolimus and Avastin in Patients With Chemotherapy Refractory Castrate Resistant Prostate Cancer (CRPC).
Phase of Trial: Phase I/II
Latest Information Update: 18 Aug 2015
At a glance
- Drugs Bevacizumab (Primary) ; Temsirolimus (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Biomarker; Pharmacogenomic; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 13 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Mar 2012 Actual patients number is 22 as reported by ClinicalTrials.gov.